| Trial ID: | L4909 |
| Source ID: | NCT02501850
|
| Associated Drug: |
Liraglutide
|
| Title: |
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
|
| Acronym: |
EGLIPA
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Liraglutide|DRUG: metformin
|
| Outcome Measures: |
Primary: Change in blood levels of Lipoprotein (a) (Lp(a)), Baseline and two months |
|
| Sponsor/Collaborators: |
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-10
|
| Completion Date: |
2015-10
|
| Results First Posted: |
|
| Last Update Posted: |
2015-07-21
|
| Locations: |
Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT02501850
|
